Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | glutathione reductase, putative | 0.0042 | 0.2288 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0067 | 0.4407 | 0.4407 |
Trypanosoma brucei | trypanothione reductase | 0.0042 | 0.2288 | 0.3039 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0067 | 0.4407 | 0.5853 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0096 | 0.6774 | 0.8837 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.007 | 0.465 | 0.4506 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.753 | 1 |
Brugia malayi | RNA binding protein | 0.007 | 0.465 | 0.6175 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0105 | 0.753 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0105 | 0.753 | 0.753 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.465 | 0.465 |
Mycobacterium tuberculosis | Probable reductase | 0.0096 | 0.6774 | 0.8837 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0096 | 0.6774 | 0.8837 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0043 | 0.2335 | 0.3101 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0015 | 0 | 0.5 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0042 | 0.2288 | 0.2985 |
Brugia malayi | TAR-binding protein | 0.007 | 0.465 | 0.6175 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0106 | 0.7665 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.753 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0015 | 0 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.0042 | 0.2288 | 0.3039 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.465 | 0.465 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0105 | 0.753 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.753 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.753 | 1 |
Leishmania major | trypanothione reductase | 0.0042 | 0.2288 | 0.3039 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0106 | 0.7665 | 1 |
Giardia lamblia | Kinase, PLK | 0.0105 | 0.753 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0052 | 0.3115 | 0.4137 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0067 | 0.4407 | 0.4407 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0105 | 0.753 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0067 | 0.4407 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0052 | 0.3115 | 0.4137 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0096 | 0.6774 | 0.8837 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0105 | 0.753 | 1 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0105 | 0.753 | 0.5 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0096 | 0.6774 | 0.8837 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0105 | 0.753 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0105 | 0.753 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0105 | 0.753 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.007 | 0.465 | 0.4506 |
Toxoplasma gondii | thioredoxin reductase | 0.0042 | 0.2288 | 0.5192 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0067 | 0.4407 | 0.5853 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.753 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0042 | 0.2288 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.465 | 0.465 |
Echinococcus granulosus | tar DNA binding protein | 0.007 | 0.465 | 0.6175 |
Trypanosoma brucei | polo-like protein kinase | 0.0105 | 0.753 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0106 | 0.7665 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0043 | 0.2335 | 0.3101 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.465 | 0.465 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0105 | 0.753 | 0.5 |
Schistosoma mansoni | kinase | 0.0053 | 0.323 | 0.323 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0067 | 0.4407 | 0.575 |
Brugia malayi | RNA recognition motif domain containing protein | 0.007 | 0.465 | 0.6175 |
Echinococcus multilocularis | tar DNA binding protein | 0.007 | 0.465 | 0.6175 |
Loa Loa (eye worm) | RNA binding protein | 0.007 | 0.465 | 0.4506 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0106 | 0.7665 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0067 | 0.4407 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.753 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0015 | 0 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0067 | 0.4407 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0042 | 0.2288 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0096 | 0.6774 | 0.8837 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0042 | 0.2288 | 0.3039 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0067 | 0.4407 | 1 |
Treponema pallidum | NADH oxidase | 0.0015 | 0 | 0.5 |
Plasmodium falciparum | thioredoxin reductase | 0.0042 | 0.2288 | 1 |
Brugia malayi | glutathione reductase | 0.0042 | 0.2288 | 0.3039 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.465 | 0.465 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.753 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0067 | 0.4407 | 0.5853 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.